2020 Japan Microbiology Analyzers and Reagent for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts by Product-Competitive Profiles, Technology and Instrumentation Review, Opportunities for Suppliers
LeadingMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key Japanese market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
Rationale
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Opportunities and Strategic Recommendations
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, Hepatitis, H. Pylori, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Geographic Coverage
France, Germany, Italy, Spain, UK
Market Segmentation Analysis
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
Contains 976 pages and 160 tables
Rationale
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Opportunities and Strategic Recommendations
- Emerging opportunities for new instrumentation, reagents kits, IT and other products with significant market appeal during the next five years.
- Design criteria for decentralized testing products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Infectious Diseases Analyzed in the Report
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, Hepatitis, H. Pylori, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.
Geographic Coverage
France, Germany, Italy, Spain, UK
Market Segmentation Analysis
- Sales and market shares of major suppliers by individual test and country.
- Volume and sales forecasts for over 100 infectious disease assays by country, individual test and market segment:
- Hospitals
- Blood Banks
- Commercial/Private Laboratories
- Public Health Laboratories
- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
- Review of the market dynamics, trends, structure, size, growth and major suppliers by country.
- In-depth examination of over 100 major diseases, including their etiology, current diagnostic tests, vaccines, drugs and market needs.
- Review of major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.
- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for infectious disease testing.
- Global listings of companies developing or marketing infectious disease diagnostic products by individual test.
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.
Contains 976 pages and 160 tables
I. INTRODUCTION
II. MARKET OVERVIEW
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. OVERVIEW OF MAJOR TESTS, TECHNOLOGIES, AND INSTRUMENTATION
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob’s Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
33. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus
56. Rubella
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semiautomated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
VIII. INFECTIOUS DISEASE TESTING MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako
II. MARKET OVERVIEW
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
V. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. OVERVIEW OF MAJOR TESTS, TECHNOLOGIES, AND INSTRUMENTATION
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus
3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter
11. Candida
12. Chagas Disease
13. Chancroid
14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob’s Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
33. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies
53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus
56. Rubella
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semiautomated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
VIII. INFECTIOUS DISEASE TESTING MARKET
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
GSK Biologicals
Hologic
Leica Biosystems
Lonza
Ortho-Clinical Diagnostics
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens Healthineers
Takara Bio
Thermo Fisher
Wako
LIST OF TABLES
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
Laboratories Performing Infectious Disease Tests by Market Segment
Hospital Laboratories Performing Infectious Disease Tests by Bed Size
Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
All Market Segments Infectious Disease Test Volume Forecast
All Market Segments Infectious Disease Test Volume by Method
Hospital Laboratories Infectious Disease Test Volume Forecast
Blood Banks Infectious Disease Test Volume Forecast
Commercial/Private Laboratories Infectious Disease Test Volume Forecast
All Market Segments Infectious Disease Diagnostics Market Forecast
Hospital Laboratories Infectious Disease Diagnostics Market Forecast
Blood Banks Infectious Disease Diagnostics Market Forecast
Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
HIV/HIV-1/2/Combo, Test Volume and Diagnostics Sales Forecast by Market Segment
HIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
BEA Test Volume and Diagnostics Sales Forecast by Market Segment
Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
Candida Test Volume and Diagnostics Sales Forecast by Market Segment
Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market Segment
Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
CMV Test Volume and Diagnostics Sales Forecast by Market Segment
Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
EBV Test Volume and Diagnostics Sales Forecast by Market Segment
Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
HCV Test Volume and Diagnostics Sales Forecast by Market Segment
HCV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
Measles Test Volume and Diagnostics Sales Forecast by Market Segment
Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
Polyoma Viruses Test Volume and Diagnostics Sales Forecast by Market Segment
Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
RSV Test Volume and Diagnostics Sales Forecast by Market Segment
Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
AIDS Testing Market Diagnostics Sales by Major Supplier
Adenovirus Testing Market Diagnostics Sales by Major Supplier
Campylobacter Testing Market Diagnostics Sales by Major Supplier
Candida Testing Market Diagnostics Sales by Major Supplier
Chlamydia Testing Market Diagnostics Sales by Major Supplier
CMV Testing Market Diagnostics Sales by Major Supplier
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Hepatitis Testing Market Diagnostics Sales by Major Supplier
Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Herpes Testing Market Diagnostics Sales by Major Supplier
Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Influenza Testing Market Diagnostics Sales by Major Supplier
Meningitis Testing Market Diagnostics Sales by Major Supplier
Mononucleosis Testing Market Diagnostics Sales by Major Supplier
Mumps Testing Market Diagnostics Sales by Major Supplier
Mycoplasma Testing Market Diagnostics Sales by Major Supplier
RSV Testing Market Diagnostics Sales by Major Supplier
Rotavirus Testing Market Diagnostics Sales by Major Supplier
Rubella Testing Market Diagnostics Sales by Major Supplier
Septicemia Testing Market Diagnostics Sales by Major Supplier
Shigella Testing Market Diagnostics Sales by Major Supplier
Streptococci Testing Market Diagnostics Sales by Major Supplier
Syphilis Testing Market Diagnostics Sales by Major Supplier
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Trichomonas Testing Market Diagnostics Sales by Major Supplier
Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
Laboratories Performing Infectious Disease Tests by Market Segment
Hospital Laboratories Performing Infectious Disease Tests by Bed Size
Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
All Market Segments Infectious Disease Test Volume Forecast
All Market Segments Infectious Disease Test Volume by Method
Hospital Laboratories Infectious Disease Test Volume Forecast
Blood Banks Infectious Disease Test Volume Forecast
Commercial/Private Laboratories Infectious Disease Test Volume Forecast
All Market Segments Infectious Disease Diagnostics Market Forecast
Hospital Laboratories Infectious Disease Diagnostics Market Forecast
Blood Banks Infectious Disease Diagnostics Market Forecast
Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
HIV/HIV-1/2/Combo, Test Volume and Diagnostics Sales Forecast by Market Segment
HIV Ag Test Volume and Diagnostics Sales Forecast by Market Segment
Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
BEA Test Volume and Diagnostics Sales Forecast by Market Segment
Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
Candida Test Volume and Diagnostics Sales Forecast by Market Segment
Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market Segment
Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
CMV Test Volume and Diagnostics Sales Forecast by Market Segment
Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
EBV Test Volume and Diagnostics Sales Forecast by Market Segment
Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
HBsAg Test Volume and Diagnostics Sales Forecast by Market Segment
HCV Test Volume and Diagnostics Sales Forecast by Market Segment
HCV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
Anti-HBc Test Volume and Diagnostics Sales Forecast by Market Segment
Anti-HBs Test Volume and Diagnostics Sales Forecast by Market Segment
Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
Measles Test Volume and Diagnostics Sales Forecast by Market Segment
Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
Polyoma Viruses Test Volume and Diagnostics Sales Forecast by Market Segment
Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
RSV Test Volume and Diagnostics Sales Forecast by Market Segment
Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
AIDS Testing Market Diagnostics Sales by Major Supplier
Adenovirus Testing Market Diagnostics Sales by Major Supplier
Campylobacter Testing Market Diagnostics Sales by Major Supplier
Candida Testing Market Diagnostics Sales by Major Supplier
Chlamydia Testing Market Diagnostics Sales by Major Supplier
CMV Testing Market Diagnostics Sales by Major Supplier
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Hepatitis Testing Market Diagnostics Sales by Major Supplier
Hepatitis C Testing Market Diagnostics Sales by Major Supplier
Herpes Testing Market Diagnostics Sales by Major Supplier
Lyme Disease Testing Market Diagnostics Sales by Major Supplier
Influenza Testing Market Diagnostics Sales by Major Supplier
Meningitis Testing Market Diagnostics Sales by Major Supplier
Mononucleosis Testing Market Diagnostics Sales by Major Supplier
Mumps Testing Market Diagnostics Sales by Major Supplier
Mycoplasma Testing Market Diagnostics Sales by Major Supplier
RSV Testing Market Diagnostics Sales by Major Supplier
Rotavirus Testing Market Diagnostics Sales by Major Supplier
Rubella Testing Market Diagnostics Sales by Major Supplier
Septicemia Testing Market Diagnostics Sales by Major Supplier
Shigella Testing Market Diagnostics Sales by Major Supplier
Streptococci Testing Market Diagnostics Sales by Major Supplier
Syphilis Testing Market Diagnostics Sales by Major Supplier
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Trichomonas Testing Market Diagnostics Sales by Major Supplier
Tuberculosis Testing Market Diagnostics Sales by Major Supplier